Professional Documents
Culture Documents
Story03 1 PDF
Story03 1 PDF
30%
10%
15%
15%
NUTRACEUTICAL PRODUCTS
2018
NUTRACEUTICAL INGREDIENTS
EXPECTED TO GROW
7,4 %
2018
SALES GLOBAL MARKET FOR
NUTRACEUTICAL INGREDIENTS
30,4 M
Biomeb
Advanced Precision Medicine
ONION WASTE
+50 %
INTESTINE CELLULAR ANTIOXIDANT DEFENSES
INDULLEIDA S.A.
ORAL
MEDICAL
DEVICE
PHARMACEUTICAL
LABORATORIES
MANUFACTURING COMPANIES
AND NUTRITIONAL
SUPPLEMENT DISTRIBUTORS
LABORATORIOS RUBI + ALIFARMA S.A.
MARKET GROW
5%
2015
2016
2017
2018
MARKET GROW
5%
475 M
0,10%
SOURCE: DBK CONSULTANT
ELIAS DAURA
Chief executive officer
MBA, PhD in Chemistry
Biomeb
Advanced Precision Medicine
ELIAS DAURA
Biomeb
Advanced Precision Medicine
2016
PORTFOLIO PRODUCTS REVENUE
Biomeb
Advanced Precision Medicine
175.000
9
1
0
2
2020
NET PROFIT GOAL
Biomeb
Advanced Precision Medicine
4,3 M
2020
NET PROFIT
Biomeb
Advanced Precision Medicine
1,2 M
PAY-BACK: 3 YEARS
IRR: 86%
PROJECTED VALUE OF BIOMEB
2016
2017
2018
2019
2020
1,6 M
Biomeb
Advanced Precision Medicine